Filing Details

Accession Number:
0001622627-25-000001
Form Type:
13D Filing
Publication Date:
2025-01-26 19:00:00
Filed By:
Rosalind Advisors, Inc.
Company:
Delcath Systems Inc. (NASDAQ:DCTH)
Filing Date:
2025-01-27
SEC Url:
13D Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Rosalind Advisors, Inc. 0 6,659,993 0 6,659,993 6,659,993 9.9%
SALAMON STEVEN A J 154,879 6,401,550 154,879 6,401,550 0 9.9%
Aharon Gil 103,564 6,401,550 103,564 6,401,550 0 9.9%
Rosalind Master Fund L.P. 0 2,871,335 0 2,871,335 2,871,335 4.7%
Rosalind Opportunities Fund I L.P. 0 3,530,215 0 3,530,215 3,530,215 4.0%
Filing





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D



Comment for Type of Reporting Person:
As more fully described in Item 5, the shares of Preferred Stock and Warrants are subject to a 9.99% blocker, and the percentage set forth in row (13) gives effect to such blockers. The securities reported in rows (8), (10) and (11) show the number of shares of Common Stock that would be issuable upon full conversion and exercise of such reported securities and do not give effect to such blockers. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported in rows (8), (10) and (11).


SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D

 
Rosalind Advisors, Inc.
 
Signature:Steven Salamon
Name/Title:Steven Salamon/President
Date:01/27/2025
 
SALAMON STEVEN A J
 
Signature:Steven Salamon
Name/Title:Steven Salamon
Date:01/27/2025
 
Aharon Gil
 
Signature:Gil Aharon
Name/Title:Gil Aharon
Date:01/27/2025
 
Rosalind Master Fund L.P.
 
Signature:Mike McDonald
Name/Title:Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
Date:01/27/2025
 
Rosalind Opportunities Fund I L.P.
 
Signature:Steven Salamon
Name/Title:Director, Rosalind Opportunities Fund I GP. Inc. (as General Partners to Rosalind Opportunities Fund I)
Date:01/27/2025